Roche immunoassay B-type natriuretic peptide precursor assay second generation
Taiwan·Risk Class 2·ROCHE DIAGNOSTICS GMBH·Registered Jul 20, 2017 – Jul 20, 2027Active- Analysis ID
- a34db0bb5334685489e9087e1e180dde
- Customs Code
- DHA05602959706
- Manufacturer
- ROCHE DIAGNOSTICS GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- ROCHE DIAGNOSTICS LTD.
- Intended Use
- Performance (specifications 08836752190 new applicable models) changes: This product uses electrochemiluminescence immunoassay (ECLIA) with cobas e 402 and cobas e 801 immunoassay analyzers to quantitatively detect N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum and plasma in vitro.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 校正品;; A.1117 B型利尿鈉肽試驗系統
- Import Information
- import
- Registration Date
- Jul 20, 2017
- Expiry Date
- Jul 20, 2027
Top companies providing products similar to "Roche immunoassay B-type natriuretic peptide precursor assay second generation"
Recently registered similar products
Access comprehensive regulatory information for Roche immunoassay B-type natriuretic peptide precursor assay second generation in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a34db0bb5334685489e9087e1e180dde and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.